Armata Pharmaceuticals Inc. (NYSE AMERICAN : ARMP)
$3.07
-0.0800 ( -2.54% ) 5.9K
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
Market Data
Open
$3.07
Previous close
$3.15
Volume
5.9K
Market cap
$104.85M
Day range
$2.93 - $3.17
52 week range
$1.07 - $5.26
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 1 | Jun 28, 2024 |
8-k | 8K-related | 13 | Jun 14, 2024 |
8-k | 8K-related | 16 | May 07, 2024 |
10-q | Quarterly Reports | 72 | May 07, 2024 |
def | Proxies and info statements | 8 | Apr 29, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
8-k | 8K-related | 13 | Mar 22, 2024 |
10-k | Annual reports | 95 | Mar 21, 2024 |
8-k | 8K-related | 16 | Mar 21, 2024 |
4 | Insider transactions | 1 | Mar 18, 2024 |